• Cefepime (BMY-28142): Applied Workflows for CNS Infection Mo

  2026-08-07

  Cefepime (BMY-28142) stands out for its robust blood-brain barrier penetration, enabling rigorous research into central nervous system infections and multidrug-resistant bacteria. This guide details advanced protocols, troubleshooting strategies, and comparative insights to help researchers maximize experimental clarity and reproducibility.

• Linezolid (SKU A5181): Advancing Gram-Positive Research Reli

  2026-08-06

  This article provides scenario-driven guidance for biomedical researchers using Linezolid (SKU A5181) in cell viability, proliferation, and cytotoxicity assays. Drawing on APExBIO's validated product data and recent literature, it addresses experimental design, protocol optimization, data interpretation, and vendor reliability, ensuring reproducible and data-backed workflows in Gram-positive bacterial research.

• Cefodizime: Third-Generation Cephalosporin Antibiotic Data S

  2026-08-06

  Cefodizime is a third-generation cephalosporin antibiotic exhibiting broad-spectrum activity and pronounced β-lactamase stability. It inhibits bacterial cell wall synthesis via penicillin-binding protein targeting. This dossier presents quantitative benchmarks, mechanistic rationale, and workflow integration guidance for research use.

• Cefodizime: Third-Generation Cephalosporin Antibiotic Profil

  2026-08-05

  Cefodizime is a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity and β-lactamase stability. Its mechanism targets bacterial cell wall synthesis via penicillin-binding proteins, making it effective for respiratory and urinary tract pathogens. The compound is kidney-safe and demonstrates immunomodulatory properties, with robust evidence for research use.

• Cell Surface Integrity Sets Ploidy Limits in Budding Yeast

  2026-08-05

  The reference study uncovers how physical properties of the cell surface restrict the maximum achievable ploidy in Saccharomyces cerevisiae. By experimentally manipulating polyploidization and surface stress, the authors link cell integrity to genome content and highlight the physiological trade-offs facing polyploid cells.

• Transmission Dynamics of Carbapenemase Genes in CREC: Insigh

  2026-08-04

  This study provides a detailed molecular epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China. Key innovations include mapping the prevalence, genetic carriers, and transmission patterns of blaNDM-1 and related resistance determinants, offering actionable insights for antimicrobial resistance surveillance and laboratory assay development.

• Methicillin Sodium Salt: Precision in MSSA Infection Models

  2026-08-04

  Methicillin sodium salt is the gold standard for distinguishing MSSA from MRSA, enabling accurate and reproducible infection models in both clinical and laboratory settings. This article details optimized workflows, troubleshooting strategies, and benchmarks tailored for Staphylococcus aureus infection research.

• Methicillin Sodium Salt: Workflow Optimization for MSSA Rese

  2026-08-03

  Methicillin sodium salt stands as a benchmark tool for modeling gram-positive bacterial infections and dissecting resistance mechanisms in Staphylococcus aureus. This article details evidence-based workflows, troubleshooting strategies, and advanced use cases that maximize the reproducibility and interpretability of MSSA experiments using APExBIO’s high-purity Methicillin sodium salt.

• Ceftolozane Sulfate: Translational Dynamics and Precision Do

  2026-08-03

  Explore the translational science behind Ceftolozane sulfate, focusing on advanced pharmacokinetic/pharmacodynamic modeling, precision dosing, and its robust bactericidal activity against Pseudomonas aeruginosa. This article uniquely bridges animal model insights with clinical assay optimization for resistant infections.

• Ceftolozane-Tazobactam in Nosocomial Pneumonia: Evidence and

  2026-08-02

  The referenced study systematically evaluates ceftolozane-tazobactam as an alternative to carbapenems for nosocomial pneumonia, focusing on activity against multidrug-resistant Pseudomonas aeruginosa and Enterobacteriaceae. Its findings clarify molecular mechanisms of action and clinical performance, informing resistance management and experimental model design.

• Vancomycin Hydrochloride: Applied Workflows in Resistance As

  2026-08-01

  Vancomycin hydrochloride from APExBIO stands apart as a gold-standard glycopeptide antibacterial agent for precision antibiotic resistance assays, selective media design, and translational infection models. This article delivers actionable protocols, advanced troubleshooting, and bridges foundational research into practical, high-impact laboratory workflows.

• 3-Deazaadenosine Hydrochloride SKU B8470: Reproducibility in

  2026-07-31

  This scenario-driven article explores how 3-Deazaadenosine hydrochloride (SKU B8470) enables reproducible, sensitive, and robust workflows in cell viability, proliferation, and methylation research. Drawing from recent evidence and peer-reviewed protocols, we address common laboratory challenges, positioning SKU B8470 as a reliable choice for methylation pathway interrogation and hepatic stellate cell studies.

• Repurposing FDA Drugs to Inhibit MERS-CoV: de Wilde et al. I

  2026-07-31

  de Wilde et al. systematically screened 348 FDA-approved compounds, identifying four agents with potent inhibitory effects against MERS-CoV in cell culture. Their findings highlight the translational value of drug repurposing for emerging viral threats and provide a foundation for rapid therapeutic development.

• XXLP Modulates NOX2/ROS/Mitochondria/NLRP3 Axis in Ulcerativ

  2026-07-30

  Xu Chunfu’s Modified Xianglian Pill (XXLP) demonstrates significant therapeutic potential for ulcerative colitis by targeting the NOX2/ROS/mitochondria/NLRP3 axis and modulating gut microbiota. The study’s integration of proteomics, molecular docking, and microbiome analysis advances mechanistic understanding and may inform novel interventions for inflammatory bowel diseases.

• Hexetidine (NSC-17764): Experimental Mastery in Oral Biofilm

  2026-07-30

  Hexetidine (NSC-17764) empowers researchers to dissect and control oral microbial communities with precision, thanks to its strain-specific activity and robust in vitro versatility. This guide translates mechanistic evidence and peer-reviewed protocols into actionable workflows, troubleshooting tips, and comparative insights for advanced biofilm and plaque studies.

456 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page